Preclinical study illuminates origin of epileptic seizures

New evidence from a zebrafish model of epilepsy may help resolve a debate into how seizures originate, according to Weill Cornell Medicine and NewYork-Presbyterian investigators. The findings may also be useful in the discovery and development of future epilepsy drugs.

Center for Immunology connects Cornell strengths

The center, with more than 120 faculty members, builds on the multidisciplinary nature of research into the immune system, with links between infection biology, vaccine development, genetics, genomics, malignancy and biomedical engineering.

Tumors change their metabolism to spread more effectively

New cancer cell research opens a new avenue for understanding how tumors spread to other tissues via metastasis, and hints at novel ways to block the spread of cancer by targeting the process.

Accessible care key to treating hep C in people who inject drugs

Among participants who had hepatitis C and who injected drugs, those treated at a non-stigmatizing “accessible care” treatment center co-located with a syringe service program were nearly three times more likely to be cured, according to new research.

SARS-CoV-2 virus can infect heart’s pacemaker cells

The SARS-CoV-2 virus can infect specialized pacemaker cells that maintain the heart’s rhythmic beat, setting off a self-destruction process within the cells, according to a preclinical study co-led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and NYU Grossman School of Medicine.

Key protein facilitates regeneration of liver blood vessels

Researchers at Weill Cornell Medicine have identified a key protein that induces the program to build specialized liver blood vessels. The discovery could lead to engineered replacement hepatic tissue to treat common liver diseases.

Pandemic prompted exodus from New York City, gains upstate

An analysis of newly released census data by the Cornell Program on Applied Demographics shows how the pandemic’s onset influenced populations in each New York state county.

Study reveals structure of anti-tumor therapy’s target

Using cutting-edge techniques, researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have visualized the structure of a receptor targeted by an anti-cancer immunotherapy. The finding may help scientists improve this type of cancer treatment.

Students celebrate Match Day at Weill Cornell Medicine

Students in the Weill Cornell Medical College Class of 2022 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.